Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

More Information

Trial Status
Accepting patients
Trial Phase
Observational Trial
Enrollment
2,300 patients (estimated)
Sponsors
Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb
Trial Type
Observational
Last Update
1 month ago
SparkCures ID
1642
NCT Identifier
NCT01688011

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.